These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12384556)

  • 21. Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.
    Anderton JA; Lindsey JC; Lusher ME; Gilbertson RJ; Bailey S; Ellison DW; Clifford SC
    Neuro Oncol; 2008 Dec; 10(6):981-94. PubMed ID: 18664619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR.
    Lorente A; Mueller W; Urdangarín E; Lázcoz P; von Deimling A; Castresana JS
    BMC Cancer; 2008 Feb; 8():61. PubMed ID: 18298842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation of PTCH1, the Patched-1 gene, in a panel of primary medulloblastomas.
    Pritchard JI; Olson JM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):47-50. PubMed ID: 18068533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.
    Lindsey JC; Lusher ME; Anderton JA; Gilbertson RJ; Ellison DW; Clifford SC
    Br J Cancer; 2007 Jul; 97(2):267-74. PubMed ID: 17579622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma.
    Pfister S; Schlaeger C; Mendrzyk F; Wittmann A; Benner A; Kulozik A; Scheurlen W; Radlwimmer B; Lichter P
    Nucleic Acids Res; 2007; 35(7):e51. PubMed ID: 17344319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies.
    Tamber MS; Bansal K; Liang ML; Mainprize TG; Salhia B; Northcott P; Taylor M; Rutka JT
    Childs Nerv Syst; 2006 Nov; 22(11):1379-94. PubMed ID: 16951964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular biology of medulloblastoma: will it ever make a difference to clinical management?
    Gilbertson RJ; Gajjar A
    J Neurooncol; 2005 Dec; 75(3):273-8. PubMed ID: 16195803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in embryonal tumours of the central nervous system.
    Sarkar C; Deb P; Sharma MC
    Childs Nerv Syst; 2005 Apr; 21(4):272-93. PubMed ID: 15682321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis of pediatric brain tumors.
    Biegel JA; Pollack IF
    Curr Oncol Rep; 2004 Nov; 6(6):445-52. PubMed ID: 15485613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M
    Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation of the RASSF1A gene in human cancers.
    Pfeifer GP; Yoon JH; Liu L; Tommasi S; Wilczynski SP; Dammann R
    Biol Chem; 2002 Jun; 383(6):907-14. PubMed ID: 12222680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.
    Lusher ME; Lindsey JC; Latif F; Pearson AD; Ellison DW; Clifford SC
    Cancer Res; 2002 Oct; 62(20):5906-11. PubMed ID: 12384556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
    Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
    Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
    Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
    Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
    Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
    Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.
    Harada K; Toyooka S; Maitra A; Maruyama R; Toyooka KO; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Minna JD; Gazdar AF
    Oncogene; 2002 Jun; 21(27):4345-9. PubMed ID: 12082624
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.